Wikipedia Vorapaxar Vorapaxar (brand name Zontivity, formerly known as SCH 530348) is a thrombin receptor ( protease-activated receptor, PAR-1) antagonist based on the natural product himbacine, discovered by Schering-Plough and developed by Merck & Co.